|
As the Nation continues to endure the consequences of recent pandemics, and with continued interest in biological weapons by nation states and other enemies, the federal government has an opportunity to address vulnerabilities in the biodefense enterprise. At this meeting, titled Meeting the Moment: Biodefense Policy, Procurement, and Public Health, the Commission intends to further explore : (1) biodefense policies and activities at the Department of Defense; (2) federal stockpile evaluation and decision-making for smallpox medical countermeasures; (3) needed authorities of the Department of Health and Human Services, including the Centers for Disease Control and Prevention; and (4) biodefense leadership.
Speakers include:
| ▪ |
The Honorable Deborah G. Rosenblum – Assistant Secretary of Defense for Nuclear, Chemical, and Biological Defense Programs, Department of Defense |
| ▪ |
The Honorable W. Craig Vanderwagen – Managing Director, East West Protection, LLC; former Assistant Secretary for Preparedness and Response, Department of Health and Human Services |
| ▪ |
Julie L. Gerberding, MD, MPH – Chief Executive Officer, Foundation for the National Institutes of Health; former Director, Centers for Disease Control and Prevention |
| ▪ |
Jeff Reczek – Director, Washington Office, Centers for Disease Control and Prevention |
| ▪ |
Laura Efros, PhD – Vice President, U.S. Government Affairs, Bavarian Nordic |
| ▪ |
Paul Williams – Senior Vice President, Products Business, Emergent BioSolutions |
| ▪ |
Jay K. Varma, MD – Executive Vice President and Chief Medical Officer. SIGA Technologies, Inc. |
The meeting will be held at 600 14th Street NW, Suite 600, Washington, DC 20005
The meeting will NOT be live-streamed.
Lunch will be provided.
|
